Literature DB >> 16643426

Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet.

Douglas B Brewer1.   

Abstract

Max Schultze published the first accurate and convincing description of platelets as part of a study devoted mainly to the white blood cells in 1865. He recognised them as a normal constituent of the blood and 'enthusiastically recommended' them as an object for further study by 'those concerned with the in-depth study of the blood of humans'. In 1882, Bizzozero demonstrated the value of this recommendation in his much more comprehensive study. He observed them microscopically in the circulating blood of living animals and in the blood removed from the blood vessels. In well-planned experiments, he showed that they were the first component of the blood to adhere to damaged blood vessel walls in vivo and, in vitro, that they were the first components of the blood to adhere to threads that subsequently became covered with fibrin.

Entities:  

Mesh:

Year:  2006        PMID: 16643426     DOI: 10.1111/j.1365-2141.2006.06036.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.

Authors:  Gabriella Passacquale; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  Prevalence of Low Platelet Count and Identification of Associating Determinants and Genetic Polymorphism in Healthy Individuals of Upper Assam, India.

Authors:  Nasreen Sultan; Santanu Kumar Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2018-09-08       Impact factor: 0.900

Review 3.  How platelets safeguard vascular integrity.

Authors:  B Ho-Tin-Noé; M Demers; D D Wagner
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 4.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 5.  Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation.

Authors:  Nadine Ludwig; Annika Hilger; Alexander Zarbock; Jan Rossaint
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

6.  Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.

Authors:  Alexander Zaslavsky; Kwan-Hyuck Baek; Ryan C Lynch; Sarah Short; Jenny Grillo; Judah Folkman; Joseph E Italiano; Sandra Ryeom
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

7.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

8.  Study of Long-Term Biocompatibility and Bio-Safety of Implantable Nanogenerators.

Authors:  Jun Li; Lei Kang; Yanhao Yu; Yin Long; Justin J Jeffery; Weibo Cai; Xudong Wang
Journal:  Nano Energy       Date:  2018-07-06       Impact factor: 17.881

Review 9.  Platelets and tumor-associated RNA transfer.

Authors:  Silvia D'Ambrosi; R Jonas Nilsson; Thomas Wurdinger
Journal:  Blood       Date:  2021-06-10       Impact factor: 22.113

Review 10.  Platelets: No longer bystanders in liver disease.

Authors:  Abhishek Chauhan; David H Adams; Steve P Watson; Patricia F Lalor
Journal:  Hepatology       Date:  2016-04-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.